Screening for Abdominal Aortic Aneurysms in the General Practice by Ultraportable Ultrasound
Key facts
- Who runs it
- Fondation Ophtalmologique Adolphe de Rothschild
- Where
- Lyon and Paris, FranceSee the 6 sites
- Trial code
- Status
- Recruiting
- People taking part
- 400 people, planned
- Started
- 2 Oct 2023
- Expected to end
- 1 Sept 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- AAA screening by a GP
- AAA screening by a radiologist
- Record updated
- 6 October 2026
Who can take part
- Age
- 50 years to 75 years
- Sex
- Men only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Male
- In the absence of a family history of AAA: Patient aged 65 to 75 years, chronic current or past smoker, active smoker (defined as having smoked at least one cigarette per day) or former smoker (defined as having quit smoking less than 20 years ago, regardless of the number of cigarettes smoked)
- If there is a family history of AAA: Patient between 50 and 75 years of age
- Express consent to participate in the study
- Affiliated or beneficiary of a social security plan
Who cannot take part
- Patient with previous AAA screening less than 5 years old
- Patient unable to understand the study / give informed consent (cognitive impairment, communication impairment)
- Patient with a legal protection measure
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 50 and 75 years old?
Where in France
- Cabinet IPSO BrotteauxLyon, FranceContact: Adrien NAEGELEN, DrTaking people
- Cabinet IPSO ItalieParis, FranceContact: Roxane LIARD, DrTaking people
- Cabinet IPSO NationParis, FranceContact: Inès DUMORTIER, DrTaking people
- Cabinet IPSO OurcqParis, FranceContact: Laurène BERNARD, DrTaking people
- Cabinet IPSO Richard-LenoirParis, FranceContact: Valentin GONZALEZ, DrTaking people
- Cabinet IPSO Saint MartinParis, FranceContact: Hervé PICARD, DrTaking people
About the trial
What the trial wants to find out
Abdominal aortic aneurysm (AAA) is a localized dilatation of a segment of the aorta artery in its abdominal portion. It affects 1.7% of men aged 65 years and older. In the high-risk population (male smokers aged 65-75 years), its prevalence is estimated to be between 2.8 and 9%. Mortality of ruptured AAAs is high (80% of deaths before hospitalization or perioperatively), whereas mortality of scheduled procedures for unruptured AAAs is less than 5%. AAA screening has been shown to significantly reduce the specific mortality rate in the medium and long term. The French National Authority for Health (HAS) recommends targeted screening for AAA by ultrasound at the radiologist. The target population is male smokers or former smokers aged 65 to 75 years, as well as all persons aged 50 to 75 years with a family history of AAA. Despite recommendations, the rate of access to targeted screening appears low. Ultrasound screening for AAA is a rapid, noninvasive, and reproducible test. It relies primarily on the measurement of the maximum diameter of the abdominal aorta in cross-section. It has been demonstrated that the learning of the ultrasound screening procedure for AAA is very fast and that the performance of non-radiologists trained in this procedure alone is similar to that of radiologists.
Read full original descriptionShow less
In addition, new ultra-portable ultrasound devices, inexpensive and with validated performances have appeared on the market in the last few years, making it possible to equip general practitioners (GPs). We propose a simplified care pathway for AAA screening, by equipping GPs with an ultra-portable ultrasound scanner and by training them to perform the screening procedure, which will be performed in the office or at the patient's home, during a usual consultation of general medicine. Our hypothesis is that this new organization will allow better access to screening for the target population, at a lower cost, compared to the current screening method recommended by the HAS (referral of the patient to the radiologist).
The 2 groups in the trial
- screening by a GPTreatment being tested
Each patient in this group will have a screening for AAA performed by a trained general practitioner
Treatment: AAA screening by a GP
- screening by a radiologist (conventional)Other group
Each patient in this group will have AAA screening performed by a radiologist
Treatment: AAA screening by a radiologist
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Screening for Abdominal Aortic Aneurysms in the General Practice by Ultraportable Ultrasound: Cluster Randomized Controlled Prospective Multicenter Study in Two Parallel Groups 1:1 in Open-label
- Fit questions
- Built from NCT05617326, who can take part
- Record updated
- 6 October 2026